Industry Urged to Involve Patients Early, Solicit Input on PROs
Device and drugmakers need to engage patients earlier in the development process to ensure they are addressing symptoms and measuring outcomes that matter to patients, patient advocates say.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.